Nanjing King-friend Biochemical Pharmaceutical Co Ltd

SSE:603707

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Nanjing King-friend Biochemical Pharmaceutical Co Ltd's stock price target?

Price Target

11.85 CNY

According to Wall Street analysts, the average 1-year price target for Nanjing King-friend Biochemical Pharmaceutical Co Ltd is 11.85 CNY with a low forecast of 10.34 CNY and a high forecast of 13.65 CNY.

What is Nanjing King-friend Biochemical Pharmaceutical Co Ltd's Revenue forecast?

Projected CAGR

13%

For the last 9 years the compound annual growth rate for Nanjing King-friend Biochemical Pharmaceutical Co Ltd's revenue is 27%. The projected CAGR for the next 3 years is 13%.

What is Nanjing King-friend Biochemical Pharmaceutical Co Ltd's Operating Income forecast?

Projected CAGR

11%

For the last 9 years the compound annual growth rate for Nanjing King-friend Biochemical Pharmaceutical Co Ltd's operating income is 35%. The projected CAGR for the next 3 years is 11%.

What is Nanjing King-friend Biochemical Pharmaceutical Co Ltd's Net Income forecast?

Projected CAGR

15%

For the last 9 years the compound annual growth rate for Nanjing King-friend Biochemical Pharmaceutical Co Ltd's net income is 28%. The projected CAGR for the next 3 years is 15%.